Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis, Drug-Induced”

82 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 82 results

Not applicableUnknownNCT02076685
What this trial is testing

NAT2 Genotyping in Re-challenge Protocol of INH Titration in Patients With Anti-TB Medications-induced Hepatitis

Who this might be right for
Hepatotoxicity
National Taiwan University Hospital 60
Early research (Phase 1)Study completedNCT01275599
What this trial is testing

Drug-Drug Interaction Study Between Telaprevir and Buprenorphine

Who this might be right for
Hepatitis COpioid-Related Disorders
Vertex Pharmaceuticals Incorporated 16
Post-approval studies (Phase 4)Study completedNCT03949764
What this trial is testing

The Kentucky Viral Hepatitis Treatment Study

Who this might be right for
Hepatitis COpioid-Related DisordersInjection Drug Use
Jennifer Havens 374
Not applicableStudy completedNCT00834353
What this trial is testing

Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis

Who this might be right for
Pulmonary Tuberculosis
Maulana Azad Medical College
Not applicableStudy completedNCT00726557
What this trial is testing

Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261)

Who this might be right for
Hepatitis C, ChronicSubstance Abuse, Intravenous
Merck Sharp & Dohme LLC 246
Not applicableStudy completedNCT03155906
What this trial is testing

Integrated Treatment of Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, ChronicOpioid Dependence, on Agonist Therapy
Haukeland University Hospital 298
Not applicableStudy completedNCT02573948
What this trial is testing

Feasibility of Interventions on People Who Inject Drugs in Vietnam

Who this might be right for
HIVHepatitis VirusSubstance Abuse
ANRS, Emerging Infectious Diseases 603
Not applicableStudy completedNCT00150098
What this trial is testing

Project UNITY - HIV Risk Reduction and Vaccine Education Interventions

Who this might be right for
HIV InfectionsHepatitis B
New York Blood Center 400
Post-approval studies (Phase 4)Study completedNCT02959775
What this trial is testing

Immunogenicity of Hepatitis B Vaccination Among Drug Users

Who this might be right for
Hepatitis B Vaccination
Shanxi Medical University 480
Not applicableStudy completedNCT02583243
What this trial is testing

Project BEST: Buprenorphine Entry Into Substance Abuse Treatment

Who this might be right for
Opioid-related DisordersHIV InfectionsHepatitis C, Chronic+1 more
Yale University 209
Post-approval studies (Phase 4)UnknownNCT01141322
What this trial is testing

Cholestatic Drug-induced Liver Injury

Who this might be right for
Hepatitis, Toxic
Taipei Veterans General Hospital, Taiwan 180
Not applicableStudy completedNCT03106194
What this trial is testing

Case Management in HCV Infected PWID

Who this might be right for
Drug Abuse, Intravenous
Hasselt University 441
Large-scale testing (Phase 3)UnknownNCT05738681
What this trial is testing

Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial

Who this might be right for
TuberculosisDrug Induced Liver InjuryHepatitis
Mahidol University 82
Not applicableActive Not RecruitingNCT05657106
What this trial is testing

Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk

Who this might be right for
Opioid-Related DisordersHepatitis C (HCV)Human Immunodeficiency Virus (HIV)+5 more
April M Young 752
Not applicableStudy completedNCT06847958
What this trial is testing

HepC Micro-elimination on MSM and TGW Population.

Who this might be right for
Hepatitis CPrEPDrugs of Abuse
Projecte dels NOMS Hispanosida 13,161
Not applicableUnknownNCT05376943
What this trial is testing

Possible Differences in HCC Course Depending on DAA Treatment

Who this might be right for
Carcinoma, HepatocellularHepatitis C Virus Infection, Response to Therapy ofDrug Effect+3 more
Medical University of Warsaw 100
Not applicableStudy completedNCT05108935
What this trial is testing

Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP

Who this might be right for
Opioid UseOpioid Use DisorderRisk Reduction+2 more
Duke University 17
Not applicableStudy completedNCT01844414
What this trial is testing

UCLA-Amity Parolee Health Promotion Study

Who this might be right for
Hepatitis BHepatitis CHIV+1 more
University of California, Los Angeles 600
Post-approval studies (Phase 4)Study completedNCT02064049
What this trial is testing

Surveillance and Treatment of Prisoners With Hepatitis C

Who this might be right for
Hepatitis C
Kirby Institute 3,692
Not applicableLooking for participantsNCT06180590
What this trial is testing

The Efficacy of Vosevi in Treating DAA-experienced Patients

Who this might be right for
Chronic Hepatitis CMedication Reaction
The Third Affiliated Hospital of Guangzhou Medical University 200
Load More Results